Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
This is a narrative review synthesizing preclinical and early-stage research on aptamers for colorectal cancer, raising opportunities rather than reporting primary trial evidence or definitive clinical results.
Early-phase in vitro characterization of a novel drug delivery system in cell lines; demonstrates proof-of-concept but lacks in vivo validation, clinical endpoints, or comparison to standard therapies.
Early-stage preclinical work demonstrating proof-of-concept for a novel DNA nanostructure in a single mouse tumor model, lacking controlled comparators, toxicity data, and mechanistic validation needed for clinical translation.
This is an early-stage proof-of-concept study of a novel nanodevice design using in vitro cell culture; it demonstrates feasibility and mechanism but provides no clinical efficacy data, animal studies, or comparison to existing therapeutics.